The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | L | Antineoplastic and immunomodulating agents | |
| 2 | L01 | Antineoplastic agents | |
| 3 | L01B | Antimetabolites | |
| 4 | L01BC | Pyrimidine analogues | |
| 5 | L01BC01 | Cytarabine |
| Active Ingredient | Description | |
|---|---|---|
| Cytarabine |
Cytarabine (ARA-C) is metabolised in vivo to ARA-CTP phosphorylated compound. This competitively inhibits DNA polymerase and may also inhibit certain acid kinase enzymes. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ALEXAN Solution for injection | Medicines Authority (MT) | MPI, EU: SmPC | |
| CYTOSAR Powder for solution for injection | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| DEPOCYTE Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
